893755-11-8

Basic information

• Product Name: [1-(3-methoxybenzyl)piperidin-4-yl]methylamine
• Synonyms: [1-(3-methoxybenzyl)piperidin-4-yl]methylamine
• CAS NO: 893755-11-8
• Molecular Formula: C14H22N2O
• Molecular Weight: 234.34
• Mol File: 893755-11-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: [1-(3-methoxybenzyl)piperidin-4-yl]methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: [1-(3-methoxybenzyl)piperidin-4-yl]methylamine(893755-11-8)
• EPA Substance Registry System: [1-(3-methoxybenzyl)piperidin-4-yl]methylamine(893755-11-8)

Safety Data

• Hazardous Substances Data: 893755-11-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
[1-(3-methoxybenzyl)piperidin-4-yl]methylamine is used as a potential pharmaceutical compound for its bioactive properties. The presence of the piperidine ring, a common structural element in many bioactive molecules, suggests that [1-(3-methoxybenzyl)piperidin-4-yl]methylamine may have therapeutic applications. Additionally, the methoxybenzyl group may provide specific interactions with biological targets, further enhancing its potential for pharmaceutical use.
Used in Drug Design and Development:
In the field of drug design and development, [1-(3-methoxybenzyl)piperidin-4-yl]methylamine can be utilized as a structural template or a building block for creating new drugs. Its unique structure and potential interactions with biological targets make it a valuable asset for designing novel therapeutic agents.
Used in Chemical Research:
[1-(3-methoxybenzyl)piperidin-4-yl]methylamine is also used as a subject of study in chemical research. Its complex structure and potential pharmaceutical applications make it an interesting compound for scientists to explore, potentially leading to new discoveries and advancements in the field of chemistry.
Overall, [1-(3-methoxybenzyl)piperidin-4-yl]methylamine is a versatile compound with potential applications in various industries, particularly in the pharmaceutical sector. Its unique structure and properties make it a valuable candidate for further research and development.

Upstream product

• 380424-20-4 4-carboxamide-1-(3-methoxybenzyl)piperidine 
• 874-98-6 1-bromomethyl-3-methoxybenzene 
• 39546-32-2 4-carboxamidopiperidine 
• 135632-53-0 tert-butyl N-(4-piperidinylmethyl)carbamate 

Relevant articles and documents

Discovery and Biological Evaluation of N-Methyl-pyrrolo[2,3- b]pyridine-5-carboxamide Derivatives as JAK1-Selective Inhibitors

Janus kinase 1 (JAK1) plays a key role in most cytokine-mediated inflammatory and autoimmune responses through JAK/STAT signaling; thus, JAK1 inhibition is a promising therapeutic strategy for several diseases. Analysis of the binding modes of current JAK inhibitors to JAK isoforms allowed the design of N-alkyl-substituted 1-H-pyrrolo[2,3-b] pyridine carboxamide as a JAK1-selective scaffold, and the synthesis of various methyl amide derivatives provided 4-((cis-1-(4-chlorobenzyl)-2-methylpiperidin-4-yl)amino)-N-methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxamide (31g) as a potent JAK1-selective inhibitor. In particular, the (S,S)-enantiomer of 31g (38a) exhibited excellent potency for JAK1 and selectivity over JAK2, JAK3, and TYK2. On investigating the effect of 31g on hepatic fibrosis, it was found that it reduces the proliferation and fibrogenic gene expression of TGF-β-induced hepatic stellate cells (HSCs). Specifically, 31g significantly inhibited TGF-β-induced migration of HSCs at 0.25 μM in wound-healing assays.

Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer’s disease

Cholinesterase inhibitor plays an important role in the treatment of patients with Alzheimer’s disease (AD). Herein, we report the medicinal chemistry efforts leading to a new series of 1,3-dimethylbenzimidazolinone derivatives. Among the synthesised compounds, 15b and 15j showed submicromolar IC50 values (15b, eeAChE IC50 = 0.39 ± 0.11 μM; 15j, eqBChE IC50 = 0.16 ± 0.04 μM) towards acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Kinetic and molecular modelling studies revealed that 15b and 15j act in a competitive manner. 15b and 15j showed neuroprotective effect against H2O2-induced oxidative damage on PC12 cells. This effect was further supported by their antioxidant activity determined in a DPPH assay in vitro. Morris water maze test confirmed the memory amelioration effect of the two compounds in a scopolamine-induced mouse model. Moreover, the hepatotoxicity of 15b and 15j was lower than tacrine. In summary, these data suggest 15b and 15j are promising multifunctional agents against AD.